EP 1343465 A2 20030917 - USE OF DNA REPAIR ENZYMES AS MMP-1 INHIBITORS
Title (en)
USE OF DNA REPAIR ENZYMES AS MMP-1 INHIBITORS
Title (de)
VERWENDUNG VON DNA-REPARATUR-ENZYMEN ALS MMP-1-INHIBITOREN
Title (fr)
UTILISATION D'ENZYMES DE REPARATION DE L'ADN EN TANT QU'INHIBITEURS DE MMP-1
Publication
Application
Priority
- DE 10063433 A 20001220
- EP 0114514 W 20011211
Abstract (en)
[origin: WO0249593A2] The invention relates to the use of photolyase enzymes and T4 endonuclease V as substances that inhibit MMP-1 in cosmetic or pharmaceutical preparations, for preventing the light-induced ageing of human skin.
IPC 1-7
IPC 8 full level
A61K 8/30 (2006.01); A61K 8/00 (2006.01); A61K 8/02 (2006.01); A61K 8/04 (2006.01); A61K 8/06 (2006.01); A61K 8/37 (2006.01); A61K 8/42 (2006.01); A61K 8/44 (2006.01); A61K 8/49 (2006.01); A61K 8/60 (2006.01); A61K 8/63 (2006.01); A61K 8/64 (2006.01); A61K 8/65 (2006.01); A61K 8/66 (2006.01); A61K 8/67 (2006.01); A61K 8/73 (2006.01); A61K 8/96 (2006.01); A61K 8/97 (2006.01); A61K 31/164 (2006.01); A61K 31/198 (2006.01); A61K 31/22 (2006.01); A61K 31/235 (2006.01); A61K 31/353 (2006.01); A61K 31/365 (2006.01); A61K 31/4188 (2006.01); A61K 31/455 (2006.01); A61K 31/7004 (2006.01); A61K 31/702 (2006.01); A61K 31/715 (2006.01); A61K 38/43 (2006.01); A61K 38/46 (2006.01); A61K 38/51 (2006.01); A61K 38/54 (2006.01); A61P 17/16 (2006.01); A61P 43/00 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP US)
A61K 8/0208 (2013.01 - EP US); A61K 8/046 (2013.01 - EP US); A61K 8/066 (2013.01 - EP US); A61K 8/068 (2013.01 - EP US); A61K 8/37 (2013.01 - EP US); A61K 8/42 (2013.01 - EP US); A61K 8/44 (2013.01 - EP US); A61K 8/49 (2013.01 - EP US); A61K 8/4973 (2013.01 - EP US); A61K 8/63 (2013.01 - EP US); A61K 8/64 (2013.01 - EP US); A61K 8/645 (2013.01 - EP US); A61K 8/65 (2013.01 - EP US); A61K 8/66 (2013.01 - EP US); A61K 8/671 (2013.01 - EP US); A61K 8/673 (2013.01 - EP US); A61K 8/675 (2013.01 - EP US); A61K 8/9711 (2017.07 - EP US); A61K 8/9717 (2017.07 - EP US); A61K 8/9722 (2017.07 - EP US); A61K 8/9728 (2017.07 - EP US); A61K 8/9761 (2017.07 - EP US); A61K 8/9767 (2017.07 - EP US); A61K 8/9789 (2017.07 - EP US); A61K 8/9794 (2017.07 - EP US); A61K 38/465 (2013.01 - EP US); A61K 38/51 (2013.01 - EP US); A61P 17/16 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61Q 19/08 (2013.01 - EP US); C12Y 301/25001 (2013.01 - EP US); C12Y 401/99003 (2013.01 - EP US); A61K 2800/782 (2013.01 - EP US)
C-Set (source: EP US)
Citation (search report)
See references of WO 0249593A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0249593 A2 20020627; WO 0249593 A3 20021227; AU 3841802 A 20020701; CA 2432531 A1 20020627; DE 10063433 A1 20020627; EP 1343465 A2 20030917; JP 2004517844 A 20040617; US 2003223982 A1 20031204
DOCDB simple family (application)
EP 0114514 W 20011211; AU 3841802 A 20011211; CA 2432531 A 20011211; DE 10063433 A 20001220; EP 01986861 A 20011211; JP 2002550935 A 20011211; US 45933903 A 20030611